{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:05:42Z","timestamp":1779379542050,"version":"3.53.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,21]]},"DOI":"10.7759\/cureus.109361","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:16:01Z","timestamp":1779376561000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Instance of Concordant Charcot-Marie-Tooth Disease and Familial Partial Lipodystrophy Type 2"],"prefix":"10.7759","author":[{"given":"Mark A","family":"Bachir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyawnna","family":"Hazzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S","family":"Bachir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Chima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljinder","family":"Chima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70110-3","article-title":"Diagnosis, natural history, and management of Charcot-Marie-Tooth disease","volume":"8","author":"Pareyson D","year":"2009","unstructured":"Pareyson D, Marchesi C. Diagnosis, natural history, and management of Charcot-Marie-Tooth disease. Lancet Neurology. 2009, 8:654-67. 10.1016\/S1474-4422(09)70110-3","journal-title":"Lancet Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.2.258","article-title":"Lamin A\/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy and insulin resistance","volume":"23","author":"Hegele RA","year":"2000","unstructured":"Hegele RA, Anderson CM, Cao H. Lamin A\/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy and insulin resistance. Diabetes Care. 2000, 23:258-9. 10.2337\/diacare.23.2.258","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown RJ","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, et al.. The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab. 2016, 101:4500-11. 10.1210\/jc.2016-2466","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2012.04.010","article-title":"How to diagnose a lipodystrophy syndrome","volume":"73","author":"Vantyghem MC","year":"2012","unstructured":"Vantyghem MC, Balavoine AS, Douillard C, et al.. How to diagnose a lipodystrophy syndrome. Ann Endocrinol. 2012, 73:170-89. 10.1016\/j.ando.2012.04.010","journal-title":"Ann Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges","volume":"10","author":"Chiquette E","year":"2017","unstructured":"Chiquette E, Oral EA, Garg A, Ara\u00fajo-Vilar D, Dhankhar P. Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges. Diabetes Metab Syndr Obes. 2017, 10:375-83. 10.2147\/DMSO.S130810","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref6","article-title":"LMNA-Related Dilated Cardiomyopathy","author":"Hershberger RE","year":"2025","unstructured":"Hershberger RE, Jordan E. LMNA-Related Dilated Cardiomyopathy. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE (ed): University of Washington, Seattle (WA); 2025."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study","volume":"59","author":"van Rijsingen IA","year":"2012","unstructured":"van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF. Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers: a European cohort study. J Am Coll Cardiol. 2012, 59:493-500. 10.1016\/j.jacc.2011.08.078","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar S","year":"2016","unstructured":"Kumar S, Baldinger SH, Gandjbakhch E, et al.. Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers. J Am Coll Cardiol. 2016, 68:2299-307. 10.1016\/j.jacc.2016.08.058","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/339274","article-title":"Homozygous defects in LMNA, encoding lamin A\/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse","volume":"70","author":"De Sandre-Giovannoli A","year":"2002","unstructured":"De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al.. Homozygous defects in LMNA, encoding lamin A\/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet. 2002, 70:726-36. 10.1086\/339274","journal-title":"Am J Hum Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050725","article-title":"Clinical spectrum of LMNA-associated type 2 familial partial lipodystrophy: a systematic review","volume":"12","author":"Fernandez-Pombo A","year":"2023","unstructured":"Fernandez-Pombo A, Diaz-Lopez EJ, Castro AI, et al.. Clinical spectrum of LMNA-associated type 2 familial partial lipodystrophy: a systematic review. Cells. 2023, 12:10.3390\/cells12050725","journal-title":"Cells"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031658","article-title":"Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities","volume":"89","author":"Vantyghem MC","year":"2004","unstructured":"Vantyghem MC, Pigny P, Maurage CA, et al.. Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalities. J Clin Endocrinol Metab. 2004, 89:5337-46. 10.1210\/jc.2003-031658","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6156.1000659","article-title":"Efficacy and safety of metreleptin in patients with partial lipodystrophy: lessons from an expanded access program","volume":"7","author":"Ajluni N","year":"2016","unstructured":"Ajluni N, Dar M, Xu J, Neidert AH, Oral EA. Efficacy and safety of metreleptin in patients with partial lipodystrophy: lessons from an expanded access program. J Diabetes Metab. 2016, 7:1-7. 10.4172\/2155-6156.1000659","journal-title":"J Diabetes Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02538-5","article-title":"Coexistence of Charcot-Marie-Tooth 1A and nondystrophic myotonia due to PMP22 duplication and SCN4A pathogenic variants: a case report","volume":"22","author":"Nan H","year":"2022","unstructured":"Nan H, Wu Y, Cui S, et al.. Coexistence of Charcot-Marie-Tooth 1A and nondystrophic myotonia due to PMP22 duplication and SCN4A pathogenic variants: a case report. BMC Neurol. 2022, 22:17. 10.1186\/s12883-021-02538-5","journal-title":"BMC Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/19491034.2018.1456217","article-title":"Lipodystrophic syndromes\u00a0due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives","volume":"9","author":"Vigouroux C","year":"2018","unstructured":"Vigouroux C, Gu\u00e9nantin AC, Vatier C, et al.. Lipodystrophic syndromes\u00a0due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives. Nucleus. 2018, 9:251-64. 10.1080\/19491034.2018.1456217","journal-title":"Nucleus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494696-a-rare-instance-of-concordant-charcot-marie-tooth-disease-and-familial-partial-lipodystrophy-type-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:16:02Z","timestamp":1779376562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494696-a-rare-instance-of-concordant-charcot-marie-tooth-disease-and-familial-partial-lipodystrophy-type-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.109361","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}